Lincoln Pharmaceuticals Limited (BOM:531633)

Lincoln Pharmaceuticals Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	7,222	6,710	6,232	5,805	5,103	4,721
Revenue Growth	14.25%	7.67%	7.35%	13.76%	8.09%	11.30%
Gross Profit Gross Profit Growth	3,665	3,522	3,262	2,975	2,646	2,502
Operating Income Operating Income Growth	853.01	840.88	890.57	895.83	805.47	876.98
Net Income Net Income Growth	968.95	878.94	823.46	933.05	728.99	693.55
Earnings Per Share EPS Growth	48.38	43.88	41.11	46.58	36.40	34.63
EPS Growth	21.13%	6.74%	-11.74%	27.98%	5.11%	11.41%

Revenue by Geography

Chart

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
India India Growth	2,782	2,360	2,180	2,172	2,040
Rest of World Rest of World Growth	3,928	3,872	3,625	2,931	2,681
Total Total Growth	6,710	6,232	5,805	5,103	4,721

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	2,768	2,407	1,957	1,524	1,080	1,151
Total Debt Total Debt Growth	34.22	44.22	-	10.67	19.97	20.44
Net Cash (Debt) Net Cash Growth	2,734	2,363	1,957	1,514	1,060	1,131
Net Cash Growth	17.91%	20.74%	29.28%	42.76%	-6.22%	20.31%
Net Cash Per Share Net Cash Per Share Growth	136.50	117.97	97.71	75.58	52.94	56.46

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	937.93	1,064	930.16	632.17	392.62	761.32
Capital Expenditures CapEx Growth	-530.73	-254.28	-190.29	-394.76	-142.59	-455.25
Free Cash Flow Free Cash Flow Growth	407.2	809.32	739.86	237.41	250.03	306.07
Free Cash Flow Growth	-48.16%	9.39%	211.64%	-5.05%	-18.31%	-49.43%

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	50.74%	52.49%	52.34%	51.24%	51.84%	52.99%
Operating Margin	11.81%	12.53%	14.29%	15.43%	15.78%	18.57%
Pretax Margin	17.72%	17.23%	17.52%	21.06%	19.69%	20.32%
Profit Margin	13.42%	13.10%	13.21%	16.07%	14.29%	14.69%
FCF Margin	5.64%	12.06%	11.87%	4.09%	4.90%	6.48%

Dividends

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 7, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Dividend Per Share Dividend Per Share Growth	1.800	1.800	1.800	1.800	1.500	1.500
Dividend Per Share Growth	0%	0%	0%	20.00%	0%	0%
Dividend Yield	0.35%	0.32%	0.33%	0.31%	0.44%	0.48%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 7, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	10.49	12.86	13.42	12.57	9.31	8.98
Forward PE	-	7.52	7.52	7.52	7.52	7.52
P/FCF Ratio	24.97	13.97	14.93	49.39	27.13	20.36
PS Ratio	1.41	1.69	1.77	2.02	1.33	1.32

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error